StockNews.AI

Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600

StockNews.AI · 12 hours

KRYSTMHCTPCVVXAVNSBRK
High Materiality8/10

AI Summary

Krystal Biotech (KRYS) is moving from the S&P SmallCap 600 to the S&P MidCap 400 as part of the July 24, 2026 rebalance. Berkshire Hathaway’s acquisition of Taylor Morrison triggers the KRYS MidCap inclusion and TMHC removal, while V2X and Tutor Perini enter/exit the SmallCap 600. The shift could lift KRYS liquidity and passive inflows around the event.

Sentiment Rationale

Index inclusions often trigger passive fund buying and improved liquidity. KRYS’s move to MidCap 400 can attract index-tracking inflows, potentially narrowing bid-ask spreads and increasing institutional ownership over weeks after the rebalance. Historical examples show modest near-term upside for name changes tied to index rebalances, with longer-term prospects tied to growth and fundamentals.

Trading Thesis

KRYS should see modest near-term upside from index inclusion and liquidity gains around the July 24 rebalance.

Market-Moving

  • KRYS inclusion in MidCap 400 ahead of July 24, 2026 open.
  • KRYS removal from SmallCap 600 may trigger passive buying.
  • TMHC removal coincides with BRK-led M&A, affecting related stocks.

Key Facts

  • KRYS moves from S&P SmallCap 600 to S&P MidCap 400, replacing TMHC.
  • KRYS exits SmallCap 600; TPC joins SmallCap 600 replacing KRYS.
  • Berkshire Hathaway acquires Taylor Morrison; close expected around July 24.
  • V2X (VVX) replaces Avanos Medical (AVNS) in SmallCap 600; AVNS sale pending.

Companies Mentioned

  • Krystal Biotech, Inc. (KRYS): Moving into MidCap 400; expected to attract index-driven buying and liquidity.
  • Taylor Morrison Home Corp. (TMHC): Being removed from MidCap 400; acquisition by Berkshire Hathaway driving rebalancing.
  • Tutor Perini Corp. (TPC): To replace KRYS in SmallCap 600, adding liquidity consequences for TPC.
  • V2X Inc. (VVX): Joins SmallCap 600; potential near-term liquidity and beta impact.
  • Avanos Medical, Inc. (AVNS): Removed from SmallCap 600; acquisition by American Industrial Partners pending close.
  • Berkshire Hathaway Inc. (BRK): M&A sponsor driving TMHC removal and broader stock-price implications around the deal.

Industry News

Category Type: Industry News. This is a benchmark index rebalance event that affects KRYS's classification, liquidity, and potential passive inflows, typical of large-cap/mid-cap reclassifications.

Related News